Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Eyebright Medical Technology (Beijing) Co., Ltd.
  6. News
  7. Summary
    688050   CNE1000041J5

EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

(688050)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Eyebright Medical Technology Co., Ltd. entered into a framework agreement to acquire a 55% stake in Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. from Wenzhou Qingda Asset Management Co., Ltd., Lu Bo and Cai Ke for CNY 20 million.

03/31/2021 EST

Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) entered into a framework agreement to acquire a 55% stake in Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. from Wenzhou Qingda Asset Management Co., Ltd., Lu Bo and Cai Ke for CNY 20 million on March 31, 2021. Under the terms, Wenzhou Qingda Asset Management Co., Ltd., Lu Bo and Cai Ke intends to transfer the equity of the target company it holds to the new transactional party and the new transactional party will transfer 18.3 million shares representing 55% stake in target company to Eyebright Medical Technology. In a related transaction, Eyebright Medical Technology will unilaterally make another capital contribution to the target company for CNY 20 million. Post completion, Eyebright Medical Technology will hold 55% stake in Jiangsu Tianyan Pharmaceutical Technology. Eyebright Medical Technology intends to use the company's own funds of CNY 40 million to acquire stake in Jiangsu Tianyan Pharmaceutical Technology. Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. reported total assets of CNY 55.5 million and net assets of CNY 18.9 million as of February 28, 2021. This transaction has been reviewed and approved at the 23rd meeting of the first Board of Directors of Eyebright Medical Technology.


ę S&P Capital IQ 2021
All news about EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
10/27Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months End..
CI
08/11Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Half Ye..
CI
07/30EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange A Share In..
CI
07/29EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange Composite ..
CI
07/29Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agr..
CI
04/19Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the First Q..
CI
03/31Eyebright Medical Technology Co., Ltd. entered into a framework agreement to acquire a ..
CI
03/30Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Full Ye..
CI
03/30Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it expects to receiv..
CI
2020Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Three Qua..
CI
More news
Financials
Sales 2021 416 M 65,1 M 65,1 M
Net income 2021 159 M 24,9 M 24,9 M
Net Debt 2021 - - -
P/E ratio 2021 161x
Yield 2021 0,11%
Capitalization 25 629 M 4 012 M 4 012 M
Capi. / Sales 2021 61,6x
Capi. / Sales 2022 42,4x
Nbr of Employees 418
Free-Float 46,4%
Chart EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Duration : Period :
Eyebright Medical Technology (Beijing) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 243,76 CNY
Average target price 322,55 CNY
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Jiang Bing Xie Chairman, General Manager & Chief Scientist
Yan Chang Guo Chief Financial Officer & Director
Dan Xuan Wang Chairman-Supervisory Board
Zhao Wang Senior Director-Technical
Yu Jiao Wang Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.40.92%4 089
STRAUMANN HOLDING AG83.42%32 606
SONOVA HOLDING AG50.57%23 380
DEMANT A/S31.01%11 476
COCHLEAR LIMITED19.93%10 616
ÖSSUR HF.-14.55%2 659